Relivion
Stimulator, Nerve, Electrical, Transcutaneous, For Migraine
Neurolief Ltd.
The following data is part of a premarket notification filed by Neurolief Ltd. with the FDA for Relivion.
Pre-market Notification Details
| Device ID | K212106 |
| 510k Number | K212106 |
| Device Name: | Relivion |
| Classification | Stimulator, Nerve, Electrical, Transcutaneous, For Migraine |
| Applicant | Neurolief Ltd. 12 Giborei Israel St. Netanya, IL 4250412 |
| Contact | Michal Kedar-datel |
| Correspondent | Janice Hogan Hogan Lovells US LLP 1735 Market Street, Suite 2320 Philadelphia, PA 19103 |
| Product Code | PCC |
| CFR Regulation Number | 882.5891 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Special |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2021-07-06 |
| Decision Date | 2021-08-02 |
| Summary: | summary |
NIH GUDID Devices
| Device Identifier | submissionNumber | Supplement |
|---|---|---|
| 17290018393014 | K212106 | 000 |
| 17290018393113 | K212106 | 000 |
| 07290018393147 | K212106 | 000 |
| 07290018393130 | K212106 | 000 |
Trademark Results [Relivion]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 RELIVION 88005409 5823083 Live/Registered |
Neurolief Ltd. 2018-06-19 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.